Search - tctmd.com

Displaying 241 - 260 of 347

Sort: Relevancy | Date

Presentation TVT 2022

Portico Navitor: Early US Clinical Experience and Update From the Portico NG (Navitor) Study

Presenter: Azeem Latib

June 08, 2022

Presentation TVT 2022

Impella-Assisted Rapid PercAx PCI and TAVR

Presenter: Michael Cryer

June 08, 2022

Presentation TVT 2022

A look forward: evidence gaps and prospective research needs to change the clinical practice of AR treatment

Presenter: Mark Russo

June 08, 2022

Presentation TVT 2022

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

Presenter: John K. Forrest

June 08, 2022

Presentation TVT 2022

The Future of Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial

Presenter: Tamim M. Nazif

June 08, 2022

Presentation TVT 2022

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Presenter: Ravi Ramana

June 08, 2022

Presentation TVT 2022

Last Remaining Myocyte: Emergency ECMO and Staged PCI + TAVR

Presenter: Joseph Walsh

June 08, 2022

Presentation TVT 2022

Current and Future Standards for THV and Delivery System Platforms

Presenter: Rahul Sharma

June 08, 2022

Presentation TVT 2022

Total "Tandem" Approach for Cardiogenic Shock: TAVR and PCI

Presenter: Geoffrey Kunz

June 08, 2022

Presentation TVT 2022

Pushing the threshold: comparing aortic regurgitation outcomes to current guidelines and the possible need for earlier intervention

Presenter: Saif Anwaruddin

June 08, 2022

Presentation TVT 2022

The undertreatment of aortic regurgitation and understanding the need for surgical alternatives

Presenter: Vinod Thourani

June 08, 2022

Presentation TVT 2022

Cardiogenic Shock With Flash TAVR: The Importance of Event Sequencing

Presenter: Mark Bieniarz

June 08, 2022

Presentation TVT 2022

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Presenter: Martin Leon

June 08, 2022

Presentation TVT 2022

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

Moderate AS With Heart Failure: Updates and Lessons From TAVR UNLOAD

Presenter: Nicolas Van Mieghem

June 08, 2022

Presentation TVT 2022

Severe AS With No Symptoms: Updates From Surgical Trials, EARLY TAVR, and EVOLVE

Presenter: Mark Russo

June 08, 2022

Presentation TVT 2022

Post-Procedure; decreasing ICU footprint, accelerated discharge

Presenter: Tsuyoshi Kaneko

June 08, 2022

Presentation TVT 2022

Peri-Procedure segment; minimizing TAVR staff, TAVR step down unit

Presenter: Andrei Pop

June 08, 2022

Presentation TVT 2022

Pre-Procedure segment; efficiently working-up your TAVR patient

Presenter: Joseph Walsh

June 08, 2022

Presentation TVT 2022

Aortic Stenosis and lack of treatment during/post COVID-19, staffing issues and efficiency programs for TAVR optimization

Presenter: Vijay Iyer

June 08, 2022

Advertisement

Portico Navitor: Early US Clinical Experience and Update From the Portico NG (Navitor) Study

Impella-Assisted Rapid PercAx PCI and TAVR

A look forward: evidence gaps and prospective research needs to change the clinical practice of AR treatment

Progress in Self-Expanding TAVR: Evolut PRO Plus and Beyond

The Future of Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Last Remaining Myocyte: Emergency ECMO and Staged PCI + TAVR

Current and Future Standards for THV and Delivery System Platforms

Total "Tandem" Approach for Cardiogenic Shock: TAVR and PCI

Pushing the threshold: comparing aortic regurgitation outcomes to current guidelines and the possible need for earlier intervention

The undertreatment of aortic regurgitation and understanding the need for surgical alternatives

Cardiogenic Shock With Flash TAVR: The Importance of Event Sequencing

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

Moderate AS With Heart Failure: Updates and Lessons From TAVR UNLOAD

Severe AS With No Symptoms: Updates From Surgical Trials, EARLY TAVR, and EVOLVE

Post-Procedure; decreasing ICU footprint, accelerated discharge

Peri-Procedure segment; minimizing TAVR staff, TAVR step down unit

Pre-Procedure segment; efficiently working-up your TAVR patient

Aortic Stenosis and lack of treatment during/post COVID-19, staffing issues and efficiency programs for TAVR optimization

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content